You are here

  • Home
  • Archive
  • Volume 41, Issue 4
  • Assessment of association between variants and haplotypes of the remaining TBX1 gene and manifestations of congenital heart defects in 22q11.2 deletion patients

Article Text

Article menu
Download PDFPDF
Electronic letters
Assessment of association between variants and haplotypes of the remaining TBX1 gene and manifestations of congenital heart defects in 22q11.2 deletion patients
  1. A Rauch1,
  2. K Devriendt2,
  3. A Koch3,
  4. R Rauch4,
  5. M Gewillig5,
  6. C Kraus1,
  7. M Weyand6,
  8. H Singer3,
  9. A Reis1,
  10. M Hofbeck4
  1. 1Institute of Human Genetics, Friedrich-Alexander University Erlangen-Nuremberg, Germany
  2. 2Centre for Human Genetics, Leuven, Belgium
  3. 3Department of Paediatric Cardiology, Friedrich-Alexander University Erlangen-Nuremberg, Germany
  4. 4Department of Pediatric Cardiology, University of Tvebingen, Germany
  5. 5Paediatric Cardiology, Leuven, Belgium
  6. 6Department of Heart Surgery of the Friedrich-Alexander University Erlangen-Nuremberg
  1. Correspondence to:
 Dr Anita Rauch
 Institute of Human Genetics, Schwabachanlage 10, 91054 Erlangen, Germany; arauchhumgenet.uni-erlangen.de

https://doi.org/10.1136/jmg.2003.010975

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Deletion 22q11.2, commonly associated with DiGeorge or velocardiofacial syndrome (DGS/VCFS; MIM 188400), is a major cause of congenital heart disease, accounting for about 5% of all congenital heart defects in live births.1 However, the presence of the deletion does not allow one to predict the phenotype, as patients with a 22q11.2 deletion usually show a broad range of clinical variation despite a common deletion size of 3 Mb.2 Observations of phenotypic discordance—especially in the heart manifestations—in monozygotic twins concordant for 22q11.2 deletion have led some investigators to postulate that the clinical variability in this disorder is generally not caused by genetic factors.3–8 Nevertheless, studies of Df1/+ mice, which model the 22q11.2 deletion from Tbx1 haploinsufficiency, showed that the penetrance of cardiovascular defects varies widely in different genetic backgrounds, thus revealing for the first time the presence of major genetic control over the phenotypic variability of 22q11.2 deletion.9 Subsequently, Vitelli et al showed that Tbx1+/−; Fgf8+/− double mutants present with a significantly higher penetrance of aortic arch artery defects than Tbx1+/−; Fgf8+/+ mutants, while Tbx1+/+; Fgf8+/− animals are normal.10 The underlying mechanism in humans is still unclear, however. There is no evidence for an imprinting effect, and we previously excluded somatic second hit deletions in tissues derived from the pharyngeal arch as a common mechanism for the clinical variability with respect to congenital heart disease.11 Recently, a preliminary association between the expression of congenital heart defects in 22q11.2 deletion patients and a certain single nucleotide polymorphism (SNP) haplotype within the promotor region of VEGF was reported.12 However, apart from non-allelic modifiers, unmasking of recessive mutations by hemizygosity has also been considered a possible modifying factor.5,13,14

    Prompted by recent reports by several …

    View Full Text

    Footnotes

    • Competing interests: none declared